BioDelivery Sciences (BDSI) Misses Q1 EPS by 1c

BioDelivery Sciences (NASDAQ: BDSI) reported Q1 EPS of ($0.36), $0.01 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $3 million versus the consensus estimate of $2.96 million.

For earnings history and earnings-related data on BioDelivery Sciences (BDSI) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown